ArticleRespiratory research2026
EpCAM deficiency causes the inflammation of lungs due to the reduction of pIgR in airway epithelium.
Article in Respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundImmune homeostasis of the tracheobronchial epithelium is essential to the defense against pathogens for the lung. EpCAM is localized in the tracheobronchial epithelium, but the function and mechanisms of it on regulating the immunity in the respiratory tract remain unclear.
methodsThe lung tissues from the EpCAM-deficient and wild type (WT) mice at E18.5, P0 and P3 stages were analyzed. The H&E staining was performed to check the morphological and histological changes of the mutant lungs. The qRT-PCR, western blot and immunofluorescence technologies were used to compare the expression and activities of genes related to inflammatory factors, immune cells and inflammation-associated signal pathways in the lungs from WT and EpCAM−/− embryos and pups.
resultsThe morphological changes and injuries of the lungs from the P3 EpCAM-deficient pups were detected. Several genes related to inflammatory factors and immune cells were upregulated in the mutant lungs. Furthermore, the lung abundant matrix metalloproteinases, such as MMP3 and MM8, were increased and the MAPK signal pathways were hyperactivated in the lungs from EpCAM−/− mice. The pIgR and IgA were significantly downregulated in the lungs from EpCAM-deficient mice. Additionally, signaling pathways regulating pIgR transcription were substantially suppressed in the lung tissues from the EpCAM−/− mice.
conclusionsThese results demonstrated the association between the EpCAM deficiency, the hyperactivation of immune signal pathways and the downregulation of pIgR in the lungs of mice, and the regulation of the pIgR expression might be the important mechanism of EpCAM on maintaining the immune homeostasis of the tracheobronchial epithelium.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.